Skip to main content

Table 4 The relative abundance of level 2 KEGG pathway of milk microbiota from different treatments

From: Impact of yeast and lactic acid bacteria on mastitis and milk microbiota composition of dairy cows

Items

Treatments

SEM

P-value

H

M

M + Y

M + L

M + Y + L

Human disease

       

 Cancers

0.1133b

0.0850b

0.1012b

0.1456a

0.1052b

0.0149

0.024

 Immune system diseases

0.0519b

0.0629a

0.0475b

0.0541b

0.0529b

0.0034

0.012

 Infectious diseases

0.4914a

0.5046a

0.5477a

0.3779b

0.4942a

0.0542

0.092

 Metabolic diseases

0.0812b

0.0956a

0.0824b

0.0874b

0.0892b

0.0039

0.028

 Neurodegenerative diseases

0.2609a

0.1935b

0.2158b

0.2304a

0.2048b

0.0193

0.049

Organismal systems

       

 Digestive system

0.0567b

0.0400c

0.0470bc

0.0767a

0.0391c

0.0069

0.002

 Environmental adaptation

0.1018b

0.0960b

0.0992b

0.1194a

0.1028b

0.0052

0.010

 Immune system

0.0361b

0.0363b

0.0259b

0.0628a

0.0341b

0.0091

0.022

Metabolism

       

 Biosynthesis of other secondary metabolites

0.7393b

0.7458b

0.6535b

1.0859a

0.7434b

0.1151

0.029

 Enzyme families

1.8068b

1.8567a

1.8796a

1.8767a

1.8676a

0.0229

0.055

Environmental information processing

       

 Signal transduction

1.7126b

1.7509b

1.8880a

1.6072c

1.8691a

0.0503

0.001

Cellular process

       

 Signaling molecules and Interaction

0.1751bc

0.1972ab

0.1576c

0.2010a

0.1682c

0.0130

0.031

 Transport and catabolism

0.3127b

0.2578b

0.2635b

0.3818a

0.2611b

0.0319

0.013

  1. 13 level 2 KEGG pathway of milk microbiota are influenced by treatments, which are classified into 5 classfications according to the pathway involved in
  2. abcMeans in the same row with significant difference (P < 0.05)